RREMX
Price
$13.41
Change
+$0.19 (+1.44%)
Updated
Jan 30 closing price
Net Assets
3.71B
VEMAX
Price
$37.12
Change
+$0.41 (+1.12%)
Updated
Jan 30 closing price
Net Assets
108.96B
Ad is loading...

RREMX vs VEMAX

Header iconRREMX vs VEMAX Comparison
Open Charts RREMX vs VEMAXBanner chart's image
RBC Emerging Markets Equity R6
Price$13.41
Change+$0.19 (+1.44%)
VolumeN/A
Net Assets3.71B
Vanguard Emerging Mkts Stock Idx Adm
Price$37.12
Change+$0.41 (+1.12%)
VolumeN/A
Net Assets108.96B
RREMX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RREMX vs. VEMAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RREMX is a StrongBuy and VEMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 109B vs. RREMX (3.71B). VEMAX pays higher dividends than RREMX: VEMAX (3.43) vs RREMX (1.57). RREMX was incepted earlier than VEMAX: RREMX (8 years) vs VEMAX (19 years). RREMX is a more actively managed with annual turnover of: 19.00 vs. VEMAX (5.00). VEMAX has a lower initial minimum investment than RREMX: VEMAX (3000) vs RREMX (250000). VEMAX annual gain was more profitable for investors over the last year : 13.85 vs. RREMX (12.40). RREMX return over 5 years is better than : 17.71 vs. VEMAX (15.47).
RREMXVEMAXRREMX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years19 years-
Gain YTD0.303-0.163-186%
Front LoadN/AN/A-
Min. Initial Investment25000030008,333%
Min. Initial Investment IRAN/AN/A-
Net Assets3.71B109B3%
Annual Yield % from dividends1.573.4346%
Returns for 1 year12.4013.8590%
Returns for 3 years1.25-4.03-31%
Returns for 5 years17.7115.47114%
Returns for 10 yearsN/A29.03-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNVS3.660.16
+4.57%
Cineverse Corp
SABR3.390.08
+2.42%
Sabre Corp
PTCT46.150.93
+2.06%
PTC Therapeutics
OPRX5.710.05
+0.88%
OptimizeRx Corp
K81.940.17
+0.21%
Kellanova